Griffon's high beta suggests exaggerated price movements, potentially providing a prime buying opportunity in a bearish market. Despite trading around its fair value, the optimistic growth prospect is encouraging.
The current market valuation of Griffon Corporation presents a potential buying opportunity, according to the analysis. The stock is perceived to be undervalued and the expected doubling of the company's earnings in the coming years shows a robust outlook.
Griffon Corporation's stock performance may be tied to increasing dividend and a 7.8% annual revenue growth despite falling earnings. This may indicate a shift towards maturity and the attraction of dividend investors.
Gapping up In reaction to earnings/guidance: •$Aehr Test Systems(AEHR.US)$+11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems) •$Tilray Brands(TLRY.US)$+5.1% Other news: •$Payoneer Global(PAYO.US)$+8.1% (to join SaP SmallCap 600) •$Atlas(ATCO.US)$+6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
Gainers: •$Kezar Life Sciences(KZR.US)$+92% (announces positive top line results from the MISSION Phase 2 trial) •$Sutro Biopharma(STRO.US)$+24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates) •$Ceragon(CRNT.US)$+17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh) •$携程网(TCOM.US)$+15.6% (In reaction to earnings/guidance) •$Apyx Medical(APYX.US)$+8% (anno...
Gainers: •$Innoviz Technologies(INVZ.US)$+18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands) •$希尔托普控股(HTH.US)$+15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
18
3
2
举报
Dino 64 :
Nio is a pre market mover alright.....DOWN.
格里丰股票讨论区
Swing @ 35.37. SL if 15m bar closes below 33.79
In reaction to earnings/guidance:
• $Aehr Test Systems(AEHR.US)$ +11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems)
• $Tilray Brands(TLRY.US)$ +5.1%
Other news:
• $Payoneer Global(PAYO.US)$ +8.1% (to join SaP SmallCap 600)
• $Atlas(ATCO.US)$ +6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
公司主营业务是消费及专业产品、家居及建筑产品,以及10.7%的国防电子。
5年来毛利率基本保持在27%左右,2021年达到了28.2%。净资产收益率除2018年达到28.8%之外,其余4年都在10.5%以下。
5年来营收除2017和2021年外,中间3年保持增长,总体增长16%。营业利润除2017年外,连续增长4年,平均增速为9.3%。净利润2018年有次暴涨,5年平均增速为21%。2018年主要是有9242万的停止经营利润。近3年来持续经营利润平均增速为29%,还是相当快的。
2022前三季度营收累计增长13.2%,营业利润增长79%,净利润增长255.8%,其中持续经营利润增长100%,增速也不低。
利润表显示利息费用占到营业利润的37%,负担还是不轻的。
5年来资产负债率从78.7%一路下滑至69%,但是2022年前三季度又回升至74%。
资产负债表显示现金明显变多,应收帐款和存货占比都正常,增速也正常。但是2022前3季...
https://time.com/6197849/metaverse-future-matthew-ball/
• $Kezar Life Sciences(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $携程网(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical(APYX.US)$ +8% (anno...
• $Innoviz Technologies(INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $希尔托普控股(HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
暂无评论